BearWorks
MSU Graduate Theses
Fall 2015

Systemic Insulin Sensitivity and Skeletal Muscle Akt Signaling in
Rats Artificially Selected for Low and High Aerobic Capacity
Kyle Levi Fulghum

As with any intellectual project, the content and views expressed in this thesis may be
considered objectionable by some readers. However, this student-scholar’s work has been
judged to have academic value by the student’s thesis committee members trained in the
discipline. The content and views expressed in this thesis are those of the student-scholar and
are not endorsed by Missouri State University, its Graduate College, or its employees.

Follow this and additional works at: https://bearworks.missouristate.edu/theses
Part of the Medical Molecular Biology Commons

Recommended Citation
Fulghum, Kyle Levi, "Systemic Insulin Sensitivity and Skeletal Muscle Akt Signaling in Rats Artificially
Selected for Low and High Aerobic Capacity" (2015). MSU Graduate Theses. 977.
https://bearworks.missouristate.edu/theses/977

This article or document was made available through BearWorks, the institutional repository of Missouri State
University. The work contained in it may be protected by copyright and require permission of the copyright holder
for reuse or redistribution.
For more information, please contact BearWorks@library.missouristate.edu.

SYSTEMIC INSULIN SENSITIVITY AND SKELETAL MUSCLE AKT
SIGNALING IN RATS ARTIFICIALLY SELECTED FOR LOW AND HIGH
AEROBIC CAPACITY

A Masters Thesis
Presented to
The Graduate College of
Missouri State University

In Partial Fulfillment
Of the Requirements for the Degree
Master of Science, Cell and Molecular Biology

By
Kyle Fulghum
December 2015

Copyright 2015 by Kyle Levi Fulghum

ii

SYSTEMIC INSULIN SENSITIVITY AND SKELETAL MUSCLE AKT
SIGNALING IN RATS ARTIFICIALLY SELECTED FOR LOW AND HIGH
AEROBIC CAPACITY
Biomedical Sciences
Missouri State University, December 2015
Master of Science
Kyle Fulghum

ABSTRACT
The mechanism(s) linking physical inactivity, obesity, and type-II diabetes are unclear. I
hypothesized low intrinsic aerobic capacity is associated with reduced systemic insulin
sensitivity via skeletal muscle insulin signaling. After 34 generations of selective
breeding, high aerobic capacity (HCR) rats exhibited an 8-fold increase in running
distance vs low aerobic capacity (LCR) rats (n=14 per group). LCR rats had higher rates
of weight gain vs HCR (p<0.05) though food consumption was constant (p=0.86) over a
12-week study. Rats were divided into 4 groups: 1) LCR-Sham Surgery, 2) LCRCatheterization, 3) HCR-Sham Surgery or 4) HCR-Catheterization (n=7 per group).
Euglycemic-hyperinsulinemic clamps on catheterized rats tested insulin sensitivity while
sham LCR and HCR were used for basal tissue analysis. Plasma insulin levels did not
differ during the clamps, but LCR required lower glucose infusion rates than HCR
(p<0.05). Upon insulin stimulation, both absolute and normalized phospho-Akt(Ser473) of
soleus muscle were significantly increased in HCR above basal group (p<0.05), but not in
LCR. No difference was observed between insulin-stimulated phospho-Akt(Ser473) of
HCR and LCR groups . These data support that LCR is linked to a reduction in insulin
sensitivity in vivo without impairments of insulin-stimulated skeletal muscle phosphoAkt(Ser473) vs HCR rats.
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INTRODUCTION

Diabetes, Obesity, and Physical Inactivity
The mechanism linking diabetes, obesity, and physical inactivity is unknown;
however, an integrated relationship appears to exist (Figure 1). Obesity increases the risk
for diabetes, and insulin resistance has been shown to develop in those who are obese
(Dwyer-Lindgren et al. 2013; Shulman 2000). Physical inactivity has been linked to an
increased risk of obesity as well. Sedentary behaviors demonstrate up to a 61% increase
in the risk for developing obesity (Tremblay and Willms 2003). Physical inactivity has
been demonstrated to reduce insulin sensitivity. After two weeks of reduced activity, the
body becomes less insulin-sensitive (Krogh-Madsen et al. 2010).
The centers for disease control and prevention (CDC) state that only 48% of
adults met physical activity guidelines in 2008 (Centers for Disease Control 2014). This
proportion is important, as the CDC links physical inactivity to an increase in risk factors
for complex diseases (Centers for Disease Control 2011).
There is a link between physical inactivity as it relates to the complex disease
phenotype of diabetes (Figure 1) Physical inactivity is associated with increased insulin
resistance, which is characteristic of type-II diabetes mellitus (TIIDM). Regions with
lower proportions of physical inactivity and lower proportions of obesity tend to have a
lower incidence of diabetes (Centers for Disease Control 2009). Taken together, there
appears to be an association between physical inactivity, obesity, and the occurrence of
diabetes.
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Figure 1: Geographical proportion of physical inactivity (A), obesity (B), and
diabetes (C) within the Unites States in 2009. The darker shaded regions represent a
higher percentage of the regional population who fit the description. Southern and
Southeastern regions appear to have the darkest shading, indicating the highest
incidences of all three phenomena. This suggests a potential link between these
observations (Centers for Disease Control 2009).
2

Insulin Resistance as a Common Mechanism?
Insulin resistance is a precursor to diabetes and has been shown to develop in
obesity (Shulman 2000). Physical inactivity has also been linked to a reduction in
peripheral insulin sensitivity, which leads to insulin resistance (Figure 2). Insulin
resistance results in a reduction in glucose uptake into cells and is associated with TIIDM
(Karp 2010; Campbell and Reece 2005). A reduction in insulin sensitivity is hallmark of
insulin resistance. This causes a reduction in insulin signaling, altering the activation of
several pathways within the cell (Karp 2010). Normal insulin signaling results in
adequate glucose uptake for appropriate energy metabolism. These observations support
an association of insulin resistance with diabetes, physical inactivity, and obesity, which
may suggest insulin resistance is a common mechanism linking these phenomena.
Insulin resistance is pronounced in skeletal muscle tissue (Wasserman and Ayala
2005). Skeletal muscle tissue comprises much of body mass and is a major consumer of
blood glucose. This is because skeletal muscle not only demands energy production for
cellular processes, but also for force generation in mobility (Sasson et al. 1987). To fully
understand the impact of insulin resistance, one must be familiar with the process of
insulin-stimulated glucose uptake (Figure 3).

Insulin Signaling and the Effects of Insulin Resistance
Insulin is a peptide hormone generally associated with the regulation of blood
glucose concentration. It is synthesized in β-cells within islets of Langerhans in the
pancreas. After a meal, carbohydrates are degraded into simple sugars and absorbed into
the bloodstream, therefore raising blood glucose levels. Due to the high glucose affinity

3

Figure 2: Two weeks of reduced ambulatory activity reduces peripheral insulin
signaling (Krogh-Madsen et al. 2010). In the x-axis of this figure, Ra refers to hepatic
glucose production and Rd refers to glucose disappearance. The black bars indicate
normal ambulatory activity whereas the white bars indicate post-intervention of two
weeks reduction in ambulatory activity. In this figure, the y-axis refers to µmol/kg of
glucose. These data demonstrate no difference in hepatic glucose production after two
weeks of reduced ambulatory activity, p>0.05. However, there is a significant
decrease in glucose disappearance rate after the reduction in ambulatory activity,
*p=0.01. Figure and data taken from (Krogh-Madsen et al. 2010).

4

Figure 3: Schematic illustration of insulin-stimulated GLUT4 translocation (Dash et
al. 2009). Insulin binding leads to recruitment and activation of the insulin receptor
substrate (IRS) and subsequent recruitment of phosphatidylinositol 3 kinase (PI3K).
This recruitment catalyzes conversion of PIP2 to PIP3, which causes phosphorylation
of Akt via PDK1and TORC2. Akt phosphorylates AS160 and suppresses GAP
activity, which then leads to an increase in GTP-bound Rab proteins that facilitate
GLUT4 vesicle translocation to the membrane. Figure taken from (Dash et al. 2009).
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of GLUT2 within pancreatic β-cells, there will be a proportionate increase in glucose
entry when blood glucose concentration rises. Glucose is converted into pyruvate and
subsequently acetylated, increasing cytosolic adenosine triphosphate (ATP)
concentration. The increased ATP concentration binds to and closes potassium ion
channels. Reduced efflux causes slight depolarization that opens voltage-sensitive
calcium ion channels. An increase in calcium concentration stimulates exocytosis of
insulin-containing vesicles (Lodish et al. 2013).
When insulin is circulated throughout the bloodstream, it binds to insulin
receptors on cells, which results in an increase in glucose uptake. Insulin binds to specific
tyrosine kinases at α-chains, causing receptor dimerization of extracellular domains via
disulfide bonds. Subsequent cross-phosphorylation of intracellular β-chains stimulates
cross-phosphorylation of intracellular tyrosine residues. Three tyrosine residues have
been identified on β-chains being involved in an activation loop. Phosphorylation
assumes a conformation apart from a newly-formed catalytic cleft and because of this
conformational change, a specific rotation is required to bring catalytic residues closer
together and open the cleft for binding substrates of intracellular proteins (Lodish et al.
2013).
Most substrates recruited to the insulin receptor within the cell have an SH2
domain; however, the insulin-receptor substrate (IRS, which does not have an SH2
domain) is also recruited. Autophosphorylation of IRS and SH2 domain-containing
proteins creates docking sites for other SH2 domain-containing proteins and
phosphotyrosine binding (PTB) domains. The initial recruitment of IRS-1 and IRS-2
provides binding sites for several proteins and activates many pathways via

6

phosphorylation (Karp 2010). IRS proteins recruit phosphatidylinositol 3 kinase (PI3K),
which converts PIP2 to PIP3 and causes phosphorylation of Akt. Akt phosphorylates
AS160 and suppresses GAP activity, which then leads to an increase in GTP-bound Rab
proteins that facilitate GLUT4 translocation to the membrane (Dash et al. 2009; White
2003; Chang et al. 2004).
Several transduction pathways are either directly or indirectly regulated by insulin
stimulation. PKB-β (Akt2) has a primary role in insulin signaling, as its depletion causes
a decrease in insulin responsiveness and glycogen synthase kinase-3 activity (GSK3)
(Jiang et al. 2003). Further, insulin-signaling components are rapidly activated. Aerobic
exercise increases glucose uptake and GSK3 activity, and hyperinsulinemia upregulates
IRS-1 and PI3K activity (Worjtaszewski et al. 2000).
In short, insulin promotes glucose uptake in healthy individuals, stimulating its
conversion into a more efficient means of energy storage such as glycogen or lipids
(Samuel and Shulman 2012). However, there exist several conditions in which insulin
sensitivity is attenuated, altered, or dysfunctional altogether. TIIDM is a common
example of this phenomenon, and is characterized by a reduction in the responsiveness of
target cells, known as insulin resistance (Campbell and Reece 2005). An individual
resistant to insulin has impaired transport of GLUT4 to the membrane (Karp 2010).
TIIDM can occur when the insulin receptor becomes resistant to insulin, which
can cause defects in insulin signaling pathways. Insulin resistance is a common, yet
complex disorder of the endocrine system that is characterized by defective receptor
signaling or overstimulation of receptors, yielding hyperglycemia (Bornfeldt and Tabas
2011). Risk factors for insulin resistance are dynamic, but these factors are frequently
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associated with obesity and sedentary lifestyle (Karp 2010). As the occurrence of obesity
and sedentary lifestyle remains high, insulin resistance manifested as TIIDM has become
a public health concern. By the year 2020, it is estimated that there will be 250 million
cases worldwide, and by the year 2050, it is estimated that one in three Americans will
have TIIDM (Shulman 2000; Samuel and Shulman 2012). Insulin resistance is commonly
present 10-20 years before an official diagnosis of TIIDM, meaning there is impairment
in insulin signaling and glucose uptake many years before any treatment plan is started.
Physical activity decreases the risk for diabetes. It has long been known that
aerobic exercise training improves insulin sensitivity (Medeiros et al. 2010;
Wojteszewski et al. 2000). Along with alterations in diet, aerobic exercise might be one
of the best natural remedies against insulin resistance; and while genetic predispositions
to diabetes might exist, lifestyle modifications greatly reduce these risks.
Profiles during a hyperinsulinemic clamp showed gene expression in skeletal
muscle with 284 genes down-regulated and 478 genes up-regulated (Figure 4). Further,
29% of genes affected were involved in translational or transcriptional regulation,
indicating a major role of insulin in regulation of protein expression (Rome et al. 2003).
Fourteen percent of transcriptional genes responsive to insulin were involved in
energy metabolism, and 12% of the genes were involved in intercellular signaling (Rome
et al. 2003). There are dynamic and complex roles for insulin in many signaling
pathways. An individual resistant to insulin may exhibit altered transcriptional and
translational regulation. Insulin resistance may alter gene expression involved in
translation, transcription, and energy metabolism. Deconditioning, which is defined as
neglecting physical activity, leads to a reduction in gene expression for insulin and
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Figure 4: Distribution of fold change in mRNA levels induced by insulin in human
skeletal muscle (Rome et al. 2003). This figure shows almost 250 genes having a 2-3
fold increase in expression upon insulin stimulation. In addition, there appears to be
almost 140 genes with a -1.5 to -2 fold decrease in expression upon the same insulin
stimulation. Insulin has a dynamic impact on gene expression and appears to modify
the expression of 762 genes.
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adipocytokine signaling. Gene expression for these categories were up-regulated in
physically conditioned muscle, suggesting that physical activity plays a role in the
diabetes (Lammers et al. 2012).

Muscle Glucose Uptake
Skeletal muscle glucose uptake is dynamic, but often it is distinguished by three
phases: an extracellular component, and transport component, and an intracellular
component (Figure 5). The interaction of these physiological mechanisms regulate
glucose uptake into skeletal muscle (Wasserman and Ayala 2005).
The extracellular component relates increased blood flow to an increase in
substrate delivery to the cell. In mice treated with sildenafil + L-arginine, which acts as a
vasodilator, glucose uptake was significantly greater in soleus and gastrocnemius muscle
tissues as compare to mice treated with a control vehicle (Ayala et al. 2007). This
suggests an important role in glucose delivery to muscle tissue in the bloodstream.
The transport component of glucose uptake indicates the importance of GLUT4
translocation to the membrane for adequate glucose uptake. GLUT4 knockout mice were
observed to have significantly less insulin-stimulated glucose uptake than control mice
(Stanford and Goodyear 2014). Further, there appears to be an exercise component
regulating GLUT4 translocation for glucose uptake. During an acute bout of exercise,
mice lacking the insulin receptor were observed to have similar glucose uptake to mice
with intact insulin receptors (Stanford and Goodyear 2014). Individuals with TIIDM
experience a reduction in blood glucose concentrations during acute bouts of exercise
because of exercise-induced glucose uptake (Rose and Richter 2005). Together, these
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Figure 5: Interaction of physiological mechanisms in control of muscle glucose
uptake (Wasserman and Ayala 2005). The first component involves substrate delivery
to the cell, known as the extracellular component. The second component involves
glucose transport from extracellular spaces into the cell, known as the membrane
component. The final component involves hexokinase phosphorylation of glucose to
maintain its presence in the cell, known as the intracellular component. Any of these
steps can be rate-limiting in glucose metabolism.
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data support the need for GLUT4 in facilitating glucose transport across the cell
membrane.
Finally, the intracellular component indicates the need for glucose to be
phosphorylated by hexokinase-II, an enzyme initiating the first step in glycolysis.
Glycolysis then catabolizes glucose into useable products for energy production (Rose
and Richter 2005).
Any component in skeletal muscle glucose uptake may be rate-limiting; however,
investigators generally agree that transport activity of glucose across the membrane is the
most common rate-limiting step (Figure 6). The transport of glucose depends on GLUT4
translocation through insulin-stimulation or exercise-mediated mechanisms (Stanford and
Goodyear 2014). Insulin resistance is observed in skeletal muscle tissue as a reduction in
glucose uptake into the cell, further supporting that transport activity is a common ratelimiting step (Rose and Richter 2005).

Modern Exercise Physiology in Medicine: New Models for Discovery
Exercise has long been known to have several health benefits. As part of a health
treatment plan, exercise is associated with positive health outcomes and sedentary
behavior is associated with a reduction in positive health outcomes (Bamman et al. 2014;
Thyfault and Krogh-Madsen 2011). Further, aerobic exercise is associated with an
increase in or maintenance of working levels of aerobic capacity (Gaesser and Rich 1984;
Pollock et al. 1987). In addition, exercise is linked to improved insulin sensitivity and has
been shown to reverse impairments in glucose uptake observed in TIIDM (Lessard et al.
2011; Medeiros et al. 2010). Sedentary behavior is linked to an increased risk of
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Figure 6: Molecular mechanisms regulating glucose uptake in skeletal muscle
(Stanford and Goodyear 2014). Scientific investigators suggest glucose membrane
transport is rate-limiting in insulin resistance. GLUT4 translocation to the membrane
is needed for glucose uptake into the cell. On the left, the figure shows insulin binding
to its receptor and recruiting IRS-1, which then recruits PI3K. This recruitment allows
phosphorylation of Akt, which is required for insulin-stimulated GLUT4 translocation.
On the right, the figure shows plausible means of exercise-stimulated glucose uptake
via GLUT4 translocation to the membrane. Stanford and Goodyear postulate Ca2+ and
calmodulin are primarily responsible for exercise-stimulated glucose uptake. Studies
support a lack of skeletal muscle glucose uptake in GLUT4 knockouts.
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developing TIIDM (Hamilton et al. 2014). From these data, exercise appears to increase
the likelihood of good health while decreasing the risks for poor health. But to fully
understand the impact of exercise on health and to what extent it aids in cellular
physiology, it may be helpful to review some history in exercise physiology.
Exercise physiology has been applied for years, but the discovery of heat
production in muscle in 1920 is where modern exercise physiology really established its
roots. In this experiment, heat production was characters at different phases of muscle
contraction, relaxation, and recovery (Hill and Hartree 1920). Much of the heat
production was anaerobic, which then began investigation on what is now known as
aerobic and anaerobic metabolism (Hartree and Hill 1923).
A.V. Hill was a long-distance runner and noticed what appeared to be a maximum
level of oxygen consumed by himself and other athletes during bouts of exercise (Hill et
al. 1924). From these observations came the term ―VO2 max,‖ which was later described
as the maximum amount of oxygen taken up by the body at peak levels of physical
exertion. At this level, any increase in physical exertion does not elicit an increase in
oxygen consumption (Hill et al. 1924).
In 1977, data were published suggesting mitochondrial adaptations in response to
exercise (Figure 7). In this study, athletes were trained for eight weeks at 45% of VO2
max with muscle biopsies taken each week. After three weeks of training, both oxidative
and glycolytic enzymatic activity increased in addition to working aerobic capacity.
These adaptations were reversed after two weeks of detraining (Henriksson and Reitman,
1977). These data support exercise benefits at the cellular level and suggest a reversal of
these benefits is associated with physical inactivity.
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Figure 7: Time course for changes in two mitochondrial enzymes and VO2 max
during training and detraining (Henriksson and Reitman 1977). The left panel shows
the effect of training on enzymatic activity. After three weeks of training, there begins
to be an increase in oxygen uptake, succinate dehydrogenase (SDH) activity, and
cytochrome c oxidase activity. At the conclusion of 8 weeks, there are significant
increases in all three measures. The right panel shows the effect of detraining or
physical inactivity on enzymatic activity. After six weeks of detraining, there are
significantly lower levels of SDH activity and cytochrome c oxidase activity.
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Aerobic capacity refers to a working percentage of VO2 max and is implicated by
a component of time. Thus, exercise training might increase the duration of a high
working percentage of VO2 max due to skeletal muscle mitochondrial adaptations and
increased cardiorespiratory fitness (Bruce 1984). Studies consistently link high aerobic
capacities with increased longevity and increased overall health; however, it has not been
easy to test the effect of aerobic capacity on different health outcomes due to many
external factors, such as training (Koch et al. 2012). In 2005, a study was published on
two lines of rats contrasting for aerobic capacities based on an endurance run to
exhaustion (Figure 8). From an NIH stock of rats, these rats were run on a treadmill at
15% and 6 m/min until exhaustion. Rats running furthest were selected to breed together,
beginning the high endurance running capacity (HCR) group to mimic high aerobic
capacity. Rats running the least were selected to breed together, beginning the low
enduring running capacity (LCR) group to mimic low aerobic capacity (Wisloff et al.
2005).
This rat model has been used in many countries and provides an unbiased model
to assess the impact of aerobic capacity on different health outcomes (Koch and Britton
2005). As mentioned before, high aerobic capacity is consistently linked with positive
health outcomes and increased longevity in an unbiased rat model (Figure 9). Further,
VO2 max has been used consistently as a measure of cardiorespiratory function and
potential, which regulates oxygen delivery for cellular energy production (Timson et al.
2008).
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Figure 8: Generation 0-11 of rats selected for low and high intrinsic endurance
running capacity (Wisloff et al. 2005). After six generations, a significant difference
was observed in endurance running capacity and after 11 generations, the difference in
endurance running capacity was 347%. Endurance running capacity is an indirect
measure of functional aerobic capacity.
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Figure 9: A prospective test of the ―aerobic hypothesis‖ in rats selectively bred to
contrast for intrinsic endurance exercise capacity (Koch et al. 2011). This figure
highlights lifespan of LCR and HCR rats at generation 14. The median life expectancy
of LCR rats was 24.0 months whereas HCR rats had a median of 34.7 months
(p<0.001).
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Aerobic Capacity in LCR and HCR Rats
VO2 max is a measure of the maximum amount of oxygen taken up by the body at
peak levels of physical exertion. At this level, any increase in physical exertion maintains
the same oxygen consumption in the body. Oxygen is essential for aerobic organisms as
its utilization is required for adenosine triphosphate (ATP) production during oxidative
phosphorylation. Oxygen is reduced in the electron transport chain and therefore able to
accept electrons via redox reactions in mitochondrial membranes. This transfer of
electrons through different complexes helps to generate energy for the inner
mitochondrial membrane to pump protons across its membrane and subsequently
generate potential energy via a pH gradient. As protons flow back across the gradient to
reestablish proton concentration equilibrium, there is production of ATP as these protons
cycle through ATP synthase (sometimes called Complex V). This coupled process of
chemiosmosis provides considerable amounts of energy production for cellular functions
(Lodish et al. 2013). Therefore, oxygen metabolism and energy transfer govern intrinsic
aerobic capacity.
As organisms evolved, the presence of oxygen within cells has increased energy
transfer 18-fold (Koch and Britton 2005). This improvement in energy transfer may have
facilitated increased survival and lifespan. Data support many diseases are a direct result
of defective mitochondria or impairments in mitochondrial oxidation/detoxification
pathways (Koch and Britton 2005). A high aerobic capacity is consistently linked with
increased longevity in unbiased rat models. The increased ability to consume and utilize
oxygen is directly related to survival in this model, as low aerobic capacity has
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demonstrated increased risks for conditions related to early morbidity. Known as the
―aerobic hypothesis,‖ a large reduction in the energy transfer of oxygen is central to
complex disease phenotype and aging in rats (Koch et al. 2011).
Whereas intrinsic aerobic capacity is primarily regarded as a genetic trait, there
are environmental interventions to increase aerobic capacity and subsequently increase
physical fitness levels (Koch and Britton 2005). Exercise is the intentional maintenance
of some component of physical fitness (Caspersen et al. 1985). Many US individuals take
no measures in maintaining or increasing components of fitness (Physical Activity,
Figure 1).
Low aerobic exercise capacity has potential to increase the risk of certain
mortality-related diseases, an theory known as the ―aerobic hypothesis‖ (Koch et al.
2011). With these observations, low aerobic capacity may be associated with a reduction
in insulin sensitivity. Hoydal and colleagues state that within an established line of
artificially selected high and low-aerobically conditioned rats, the rats of low aerobic
capacity portrayed greater insulin resistance (Hoydal et al. 2014).
Aerobic exercise is associated with increases in functional aerobic capacity (Short
et al. 2003). Insulin signaling and glucose transport ex vivo is lower in rats artificially
bred for low-aerobic capacity as compared with high-aerobic capacity rats. In skeletal
muscle, aerobic exercise training increases aerobic capacity and reverses many
impairments to glucose metabolism (Lessard et al. 2011). While a correlation between
physical activity and insulin signaling may exist, it remains unclear whether physical
activity and aerobic capacity regulate insulin signaling in vivo.
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AKT (Protein Kinase B) of the Insulin Signaling Pathway
Phosphorylation of protein kinase B (PKB or Akt) is a common measure of
functional insulin signaling (Manning and Cantley 2007). Insulin-mediated activation of
Akt gives stimulates translocation of the GLUT4 vesicle to the plasma membrane for
glucose uptake (Gonzales and McGraw 2009). Akt has been demonstrated to be required
for appropriate GLUT4 translocation to the membrane and to maintain glucose
homeostasis. Further, insulin signaling is often measured indirectly as a function of
protein kinase activation by probing for phosphorylated Akt (Ser473) and its associated
substrates (Lessard et al. 2011).
Akt is a versatile protein kinase and an important signaling node in higher
eukaryotic cells. Its abundance throughout all cell types renders its central role in
regulation of human physiology and complex disease. (Manning and Cantley 2007). Akt
exists in three isoforms (Akt1, Akt2, and Akt3), each with unique functions and likely
subcellular specificity. Akt1 is the most prevalent isoform in endothelial cells and
functions in angiogenesis and cell growth. This is made evident as Akt1 knockout mice
do not grow to be as large as wilder-type counterparts, which is possibly due to the ability
of Akt to activate endothelial nitric oxide synthase via phosphorylation of S1177,
therefore increasing vascular remodeling and vasodilation consistent with angiogenesis
and growth (Manning and Cantley 2007; Gonzalez and McGraw 2009).
Akt2 is the most prevalent isoform in tissues that are sensitive to insulin. Its
activation stimulates GLUT4 translocation to the plasma membrane (Manning and
Cantley 2007). Akt2 knockout mice manifest impairments in glucose utilization similar to
that of Type-II diabetes mellitus (Gonzales and McGraw 2009). Hypotheses have been
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made suggesting that insulin will preferentially accumulate Akt2 in insulin-sensitive
tissues, over other Akt isoforms, to the plasma membrane. Although this might be true,
the mechanism for this observation is not clear (Gonzalez and McGraw 2009).
Finally, Akt3 is thought to function in neuronal development as Akt3 knockout
mice show impairments in early brain development (Gonzalez and McGraw 2009).
Recent data suggest a link between insulin resistance and cognitive impairment (Biessels
and Kappelle 2005; Liu et al. 2011; Ferreira et al. 2014). Insulin is known to play some
kind of role in learning, memory, and neuromodulatory functions (De Felice et al. 2014).
In summary, there exists an unidentified mechanism linking diabetes, obesity, and
physical inactivity. A common phenomenon observed in each condition is reduced
insulin sensitivity (Dwyer-Lindgren et al. 2013; Shulman 2000; Tremblay and Wilms
2003). Physical inactivity is associated with reductions in insulin sensitivity, and
sedentary behavior has been consistently linked to poor health outcomes. Conversely,
physical activity has demonstrated reversal in metabolic impairments and has been
consistently linked to positive health outcomes (Medeiros et al. 2010; Lessard et al. 2011;
Koch et al. 2009). Appropriate insulin signaling is crucial to maintain energy metabolism
(Campbell and Reece 2005). Exercise is an intentional form of physical activity with the
intention of improving physical fitness, and exercise may result in skeletal muscle
metabolic adaptations which are reversed due to physical inactivity (Caspersen et al.
1985; Henriksson and Reitmann 1977). These adaptations may help increase functional
levels of aerobic capacity (Henriksson and Reitmann 1977). High aerobic capacity is
associated with increased health and longevity in rat models, with data suggesting insulin
resistance in LCR rats ex vivo as compared to HCR rats (Koch et al. 2009; Lessard et al.
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2011). Together, these data and observations may support a link between low aerobic
capacity and reductions in insulin sensitivity which manifest through insulin signaling
protein expression.

Hypotheses
My hypotheses were as follows: 1) Low aerobic capacity is associated with
reduced whole-body insulin sensitivity in a conscious, unrestrained rat and 2) Low
aerobic capacity is associated with reductions in Akt signaling in slow, oxidative skeletal
muscle (soleus).
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MATERIALS AND METHODS

Research Compliance
All research compliance training and certification was obtained via CITI modules
in October, 2013. This project followed guidelines set forth by both an Institutional
Review Board and a Situational Animal Care and Use Committee in the spring of 2014.
Animals used in this study were treated according to an approved protocol such that
appropriate care and oversight was ensured.

Obtaining and Preparing Rat Cohorts
Aerobic capacity is a predictor of mortality and strongly associated with longevity
(Koch et al. 2012). Further, aerobic exercise has been shown to reduce insulin resistance
(Medeiros et al. 2010). Together, these observations imply that aerobic capacity might
play a role in insulin resistance and might be associated with a type-II diabetes mellitus
phenotype.
The selection process began with a founder population of heterogeneous N:NIH
rats (n=168). Through an inclined run to exhaustion, investigators ascertained intrinsic
aerobic capacity since a relationship exists between running velocity and oxygen
consumption (Koch and Britton 2001). Rats running farthest were selected to breed
together to begin the high aerobic capacity line; rats running the least amount were
selected to breed together to begin the low aerobic capacity line. To maintain genetic
variation, a rotating cycle of 13 rat families was scheduled to keep the rate of inbreeding
less than 1%, which also helped reduce environmental variance (Koch and Britton 2005).
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Divergent lines became significantly apparent within 6 generations (Koch and Britton
2001). After 11 generations, there was observed to be a 347% difference in running
capacity, suggesting there may be a difference in intrinsic aerobic capacity (Wisloff et al.
2005). Using this rat model, both genetic and environmental influences affecting aerobic
capacity and cellular physiology can be examined (Koch et al. 2012).
To test the hypotheses listed above, LCR and HCR rat cohorts following 34
generations of selective breeding were obtained from the University of Michigan. HCR
rats ran further than LCR rats, suggesting an intrinsic difference in aerobic capacity,
p<0.001 (Figure 10). Fourteen HCR rats and fourteen LCR rats were used in this study
beginning in April, 2014. Rats were housed singly, maintained on a 12-hour light/dark
schedule, and acclimated for least two weeks upon arrival.

Body Mass and Food Consumption
Body mass measurements and food consumption measurements were made once
per week throughout the duration of survival studies. Rats were massed in a tared
container on an electronic triple beam balance. Food mass for each week was measured
in a tared container on an electronic triple beam balance. Data were plotted in excel
spreadsheets and graphs were made to observe change in mass over time. In addition,
transformed data were obtained by dividing the mass of food consumed each week by the
average body mass for each week. Data included in this project reflects results after 12
weeks of data collection. After 12 weeks, LCR and HCR rats were sub-divided to one of
four groups for in vivo data collection.
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Figure 10: Running distance to exhaustion of HCR and LCR rats obtained from
University of Michigan after 34 generations. Endurance running capacity is a good
indication of intrinsic aerobic capacity. The HCR rats on average ran 10X further than
LCR rats (p<10-17). The difference in intrinsic aerobic capacity manifests with this initial
treadmill running test to exhaustion, ***p<0.001.
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Group Assignments
To determine the impact of aerobic capacity on insulin sensitivity and insulin
signaling, LCR and HCR rats were divided and weight-matched into one of two groups:
basal (B) or insulin-stimulated (IS). Rats in the IS group were catheterized and clamped,
as described below. Rats in the B group underwent a similar, sham surgery. The final
groups were as follows: LCR-B (n=7), LCR-IS (n=7), HCR-B(n=7), and HCR-IS (n=7).
Since surgery survival was not 100%, the final groups used in the analysis were as
follows: LCR-B (n=4), LCR-IS (n=3), HCR-B (n=7), and HCR-IS (n=5). Groups were
assigned based on body mass at week 12 so there was no difference between groups
within LCR and HCR cohorts.

Mouse Antenna for Sampling Access (MASA) Production
The MASA is a device constructed to isolate and secure intravenous catheters on
the back of a rat necks for placement, sampling, and ease of access to catheter tubing.
MASA construction included silicone medical adhesive, Tygon 0.02‖x0.06‖x0.02‖
tubing (Fisher Scientific), 0.132‖x0.183‖ tubing (Fisher Scientific), and 22G blunt
hypodermic tubing. Twenty-two gauge blunted needles were used for connecting the
MASA to the catheters.
First, 1 ½ 22G needles were blunted on two sides using a file and pliers to a
needle length of 24.0 mm. Then, two pieces of 0.02‖x0.06‖x0.02‖ tubing were cut to
lengths of 50.0 mm. One piece of tubing was colored red and designated for the arterial
line while the other tubing was colored black and designated for the venous line. These
tubes were each connected to blunted, 22G needles. After tubing was connected to
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blunted needles, the needles were bent to a 135o angle and positioned 45o from each other
. A 22.0 mm piece of 0.132‖x0.183‖ tubing was cut and placed over the two smaller
tubes so the red tubing was on the left when the needles were pointing away (This would
ensure the red tubing was always assigned to the left carotid artery per surgery protocol).
Finally, silicone adhesive was placed on a plastic weigh boat and the MASA was placed
in the adhesive and adjusted for desired formation. All MASAs were autoclaved and
prefilled with 10 mU/mL heparinized saline prior to use in surgery. Final angle
measurements, lengths, and placement varied as each MASA was customized to fit each
rat in surgery.

Carotid and Jugular Catheterization
Under guidance from Missouri State University’s veterinarian and IACUC panel,
surgery protocol was approved and practiced on Sprague-Dawley rats before beginning
LCR and HCR surgeries. LCR-IS (n=7) and HCR-IS (n=7) underwent a catheterization
procedure as described by Ayala et. al (2011) to include the left carotid artery and the
right jugular vein. The surgery required the following sterile instruments: 10 cm straight,
serrated, extra fine Graefe forceps (FST by Dumont), 10 cm curved, serrated, Graefe
forceps (FST by Dumon), 3 mm straight Vannas spring scissors (LaCrosse Stainless), 10
cm sharp Iris scissors (LaCrosse Stainless), 12.5 cm Halsey micro needle holder, 12.5 cm
straight and smooth ultra-fine Hemostat (FST by Dumont), serrated Adson forceps (FST
by Dumont), and 2 teeth curved Iris forceps. The body mass of each rat was taken prior to
surgery preparation so antibiotic injection could be calculated. The surgical table was
sterilized with 70% bleach followed by 70% isopropanol, and bench guards were taped
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down prior to surgery. A heating pad was set on low and a sterile, surgical drape was
taped over the heating pad. Finally, the anesthesia nose-cone was placed on one end of
the surgical field and taped down. A surgical tray was sanitized with 70% ethanol, as
were all surgical instruments prior to surgery. The tray was then filled with 1 part
cyclohexamide to 200 parts cool water with all surgical instruments placed inside the
surgical tray until needed.
Rats were placed in chamber pre-filled with 3-4% isoflurane anesthetic gas. Upon
anesthetization, rats were transferred to the surgical field with the nose placed in the
nose-cone for continuous oxygen/anesthesia administration throughout surgery. The rat
was prepared for surgery by shaving the neck from the chin to the xiphoid process, and
outward to the shoulder. Claws were clipped and puralube ophthalmic ointment (Dechra)
was applied. The rat was flipped and shaved from the base of the skull to the
shoulderblades, and outward to the sides of the neck. After the rat was prepared for
surgery, the rat was raised off the surgical drape and a new, sterile drape was placed
between the rat and the heating pad. Preparation continued with application of betadine
solution to recently shaved areas. Extremities were taped down before placing a sterile
drape over the rat.
A small, midline incision was made from the hyoid to the middle of the base of
the sternum. Tissue was blunt-dissected to expose the sternomastoid muscle on the left
side of the rat. The muscle was reflected to expose the left carotid artery and extra tissue
was teased off the artery. Before isolation of the artery, it was important to isolate the
vagus nerve away from the artery. After the artery was isolated with forceps, the artery
was tied off with silk suture (Fine Science) at the cephalic end and a loose knot was tied
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at the caudal end. A small incision was made in the artery for insertion of a sterile,
beveled catheter which was prefilled with 10 mU/mL heparinized saline. This catheter
was tied securely to the artery and patency was tested using a syringe and blunted needle
for catheter access before clamping the catheter with a sterile pin.
On the right side of the rat, tissue was teased until the jugular vein was isolated.
The vein was tied at cephalic and caudal ends as previously described and a small
incision was made. A sterile, beveled catheter was prefilled with 10 mU/mL heparinized
saline before placement into the jugular vein. The catheter was tied securely before
testing patency with a syringe and blunted needle attached to the catheter. After patency
was ensured, the catheter was clamped with a sterile pin.
When both lines were patent, the rat was flipped dorsally to expose the back. A
small incision was made between shoulder blades extending from the base of the skull. A
blunted needle was tunneled from the ventral incision around both sides of the neck to the
interscapular incision made on the back. The catheters were threaded through the blunted
needle such that the catheter placement in the front of the body resulted in catheters being
run out the dorsal incision.
The MASA was placed in the interscapular incision. Blunted needles extending
from the MASA were custom-bent to fit the incision and meet the catheters. The carotid
line in the MASA was clamped, cut to desired length, and attached to the MASA. The
jugular line in the MASA was clamped, cut to desired length, and attached to the MASA.
Patency was confirmed after unclamping the MASA by using syringes and blunted
needles to draw up blood. A lock solution of 50 mU/mL heparinized saline in 10%
glycerol was inserted in the MASA lines to reach into the catheters.

30

Antibiotic and pain-relieving injections were administered. Medications consisted
of Metacam (0.15 mg/kg), Baytril antibiotic (10 mg/kg), and 3.0 mL saline subcutaneous
injections.
Incisions were closed with nylon suture and 2% mupirocin ointment (Dechra) or
Neosporin (Johnson & Johnson) was applied to the incision. Lidocaine ointment (Taro
Pharmaceuticals) was applied on and around the sites of incision for pain relief. The rat
was given oxygen for a short time until observed to slightly regain consciousness, when
the rat was transferred to a clean cage for recovery. The cage was half-placed on a
heating pad for 24 hours to aid in the recovery process, with food and water available at
all times. Each day the body weight was monitored in addition to overall wellbeing. Rats
were deemed unsuccessful in surgery if the body mass dropped more than 20% from preoperative body mass or if overall appearance did not seem healthy (such as staggered
breathing or foaming at mouth).
Daily post-operative care included testing catheter patency and flushing catheters
with heparinized saline solution. Observations and care included measuring body mass,
applying antibiotic ointment, and making notes about the overall health and appearance
of the rat. Rats were allowed to recover at least 5 days and no more than 7 days before
performing a metabolic clamp procedure (as described below). Other materials used but
not previously mentioned are trimmers, sterile boxes, gauze, cotton swabs, sterile saline
solutions, and other sterilized surgical instruments as needed.
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Euglycemic-Hyperinsulinemic Clamp
A euglycemic-hyperinsulinemic clamp was performed to measure insulin
sensitivity (Ayala et al. 2011). This procedure involved a steady infusion of insulin while
altering glucose administration until a target value of blood glucose concentration was
obtained (Figure 11). Literature suggests a clamped value of blood glucose concentration
to be 130 mg/dL. This procedure allowed for accurate measurement of blood glucose
concentration and determination of insulin sensitivity (Tam et al. 2012). This clamp
procedure provided a good way to measure insulin sensitivity and therefore define an
insulin-resistant phenotype commonly manifested in TIIDM.
Rats fasted 5 hours prior to the clamp procedure, where t=0 min refers to the time
immediately following the conclusion of the fast. Rats in B groups began fasting 1 hour
prior to rats in IS groups. This allowed for time to euthanize a rat from the B group and
harvest tissues in the same day before beginning the clamp procedure for an IS rat. All
rats were massed prior to fasting so calculated values of 0.25 mU/µL insulin
administration could be made to infuse at 4 mU/kg/min. Insulin was made using 50.0 µL
of 100 U/mL insulin (Novolin) placed into 20.0 mL 3.0% albuminized saline (600.0 µL
plasma in 19.4 mL saline). Glucose was purchased as a 50% dextrose solution. The
arterial line used for blood sampling was prefilled with 10 U/mL heparinized saline,
while the glucose and insulin lines were prefilled with respective solutions. The glucose
and insulin lines were connected via a y-connector to provide steady infusions of each
into the jugular line.

32

A)

B)

Figure 11: Experimental design for the euglycemic-hyperinsulinemic clamp procedure.
Panel A) shows the time layout from the beginning of the fast (t=-300 min.) to the
infusion of glucose and insulin (t=120 min.). Insulin was infused constantly at 4
mU/kg/min whereas glucose was infused at variable rates so as to plateau blood glucose
concentration at 130 mg/dL. The red blood droplets indicate blood glucose readings that
were taken every 10 minutes during the metabolic clamp procedure. Panel B) displays the
setup of insulin and glucose infusion pumps into the jugular vein of a catheterized rat and
blood sampling access from the carotid artery.
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IS rats were connected to the arterial sampling line and jugular infusion line two
hours prior to the start of the clamp procedure to acclimate to the setup so the procedure
accurately reflected results of insulin sensitivity in a conscious, unrestrained rat.
The first blood sample was taken at t=-10 min for a baseline reading to ensure the
rat was not hypoglycemic and also to set an initial glucose infusion rate. A small sample
of blood was taken in a capillary tube for hematocrit reading. Insulin was administered
via the infusion pump just seconds before glucose so activation of signaling pathways
would prevent hyperglycemia. Blood glucose readings were taken at t=0 min and then in
10 minute intervals for the duration of the 2-hour clamp procedure. Fresh arterial blood
was drawn from the carotid artery and read on a ReliOn Prime glucose meter with ReliOn
Prime blood glucose test strips (Walmart). Blood glucose measurements, along with
glucose infusion rates, were recorded throughout the duration of the clamp procedure
until the target blood glucose range of about 130 mg/dL was obtained for consecutive
readings. After each blood glucose readings, the glucose infusion rate was adjusted in
accordance with the reading in attempt to obtain the target reading of 130 mg/dL. At the
conclusion of the study, a small sample of arterial blood was taken for hematocrit reading
to ensure minimal loss of blood during the study. About 1.0 mL of blood was taken from
the arterial line for plasma insulin concentration at t=120 min. All blood samples were
taken with heparin-coated syringes and the blood was placed into prelabeled EDTAcoated tubes.
Blood samples were centrifuged for 4 min at 4.0 oC and plasma supernatant was
transferred to 1.5 mL prelabeled microcentrifuge tubes and stored in a freezer at -80.0 oC
until Magpix (Merck) analysis.
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After blood samples were taken, rats were anesthetized in a chamber prefilled
with 3-4% isoflurane gas so that tissues could be harvesting.

Tissue Harvesting
Immediately following the clamp procedure, insulin-stimulated blood samples
were taken from the carotid arterial line of IS rats. IS rats were immediately placed under
3-4% isoflurane gas anesthesia before tissue collection. Rats in B groups were taken from
the cage at the conclusion of the 5-hour fast and placed in a chamber prefilled with 3-4%
isoflurane gas for anesthetization. Both tissue and blood collection was performed under
anesthesia for rats in B groups. Blood samples were taken from B groups via a heart stick
prior to tissue collection. Capillary tubes were used to determine hematocrit levels of IS
rats both before and after the clamp procedure and analyzed by centrifuging samples and
reading on a hematocrit reader.
The surgical table was sanitized and a benchguard taped down before transferring
the rat from the isoflurane chamber to the nose-cone administration of gaseous
anesthesia. All instruments were sterilized with 70% ethanol along with the surgical tray.
The tray was filled with 1 part cyclohexamide to 200 parts cool water and the instruments
were placed in the surgical tray for the entirety of tissue harvesting procedures. This
ensured sterility as tissues were being harvested.
The gastrocnemius, soleus, plantaris, liver, heart, epididymal fat, mesenteric fat,
and brain samples were harvested (Morris) for protein analysis using a 10.0 cm straight,
serrated, an extra fine Graefe forceps, and a 10.0 cm sharp Iris scissors. Samples were
rinsed in ice-chilled PBS and were dabbed on sterile gauze before being wrapped in

35

prelabeled aluminum foil and immediately flash-frozen in liquid nitrogen. Samples were
transferred to Missouri State University where the samples were stored at -80.0 oC for
future analysis. Brain samples were dissected by Margaret Thornton and Katelyn Moore.

Tissue Homogenization
Forty soleus muscle samples from basal and insulin-stimulated LCR and HCR
rats were taken from -80 oC storage and placed into liquid nitrogen. Muscle mass was
recorded in milligrams using an electronic triple beam balance (Mettler Toledo). Samples
were again placed in liquid nitrogen following mass measurement. Two 1.50 mL
microcentrifuge tubes were labeled for each soleus muscle homogenate and chilled on
ice. The Tris-Triton buffer used in the working lysis buffer was comprised of the
following materials: 10 mM Tris (pH=7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1% Triton x-100, 10% glycerol, 0.10% SDS, and 0.50% deoxycholete. The working lysis
buffer was prepared using 99 µL of the Tris-Triton buffer and 1 µL proteinase inhibitor
cocktail (Sigma P8340) per 10 mg of muscle sample. This lysis buffer of 100 µL
buffer/10 mg muscle was transferred into a prechilled 10.0 mL glass tube, using a 1000
mL pipet, for muscle tissue homogenization. Muscle tissues were transferred from liquid
nitrogen one sample at a time into a mortar that was prechilled in liquid nitrogen. The
muscle sample was then crushed using a prechilled pestal until the tissue resembled a
powder. The muscle powder was then transferred to the prechilled 10.0 mL glass tube
where the sample was lysed using a probe to grind tissue and mix with the lysis buffer.
Upon completion of muscle tissue lysis, the homogenate was transferred to 1.50 mL

36

prechilled and prelabeled microcentrifuge tubes using a 1000 mL pipet with a widened
tip for efficient transfer.
When all muscle homogenate had been collected, samples were centrifuged at 4
o

C for 15 minutes and the supernatant was transferred to 1.50 mL prelabeled and

prechilled microcentrifuge tubes. Exactly 10.0 µL of each supernatant was transferred to
a 500 µL prelabeled, prechilled microcentrifuge tube for use in a BCA assay that would
determine protein content. The remaining soluble muscle homogenate was stored at -80.0
o

C until further analysis.

Bicinchoninic assay (BCA)
A BCA protein assay was performed to determine protein concentration (Figure
12). A stock solution of BSA was prepared by measuring 48 mg albumin (Abcam) on an
electronic triple beam balance and mixing with 10.0 mL phosphate buffered saline (PBS).
Ten standards were prepared to suit the following concentrations: 600 µg/mL, 300
µg/mL, 150 µg/mL, 75 µg/mL, 37.5 µg/mL, 18.75 µg/mL, 9.375 µg/mL, 4.6875 µg/mL,
2.34375 µg/mL, and a blank negative control of 0 µg/mL. Muscle homogenate was
allowed to thaw on ice while the standards were prepared. All muscle tissue samples
were then diluted 1:20 using 15 µL of sample and 285 µL of PBS. 12000 µL of 1:50
working reagent was made for the assay by combining 11764.7 µL reagent A with 235.3
µL reagent B. This volume would allow enough working reagent for duplicates of the
standards and unknown samples in a 96-well plate. 100 µL of standards and unknown
samples were added to a 96-well clear bottom microplate, followed by 100 µL of
working reagent. The plate was then sealed and incubated at 37.0 oC for 1 hour.
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Figure 12: Standard curve for BCA protein assay of soleus muscle tissue. All unknown
samples had absorbencies within this standard curve that allowed for interpolation and
subsequent determination of protein concentration, followed by multiplying by a dilution
factor of 20. Recording absorbance at 562 nm yielded a best-fit standard curve of y =
3.4009x + 0.1564, with R2 = 0.9799.
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The assay was performed using a Molecular Devices SpectraMax Paradigm
machine. Paradigm SMP was opened and connected to the machine via computer. ABSMONO was selected to begin the assay and the wavelength was set to 562 nm. The plate
selected for the assay was defined as 96 Well Standard clrbtm. The reading area was
highlighted and assignments were made to all standards and unknown samples. The plate
was shaken on medium intensity for 5 seconds prior to reading absorbencies.
A standard curve was prepared by plotting the average absorbance of the standards
against the designated concentration. The concentration of unknown samples was
calculated using the standard curve best-fit equation and multiplying by the dilution
factor of 20. Once the concentration of each sample was determined, total protein content
could be determined for appropriate future Magpix analysis.
Absorbency data from Paradigm SMP were plotted and graphed in Excel to
produce the standard curve. This curve was used for interpolation of sample protein
concentration.

Magpix
Insulin in plasma samples were analyzed for comparison between LCR basal,
LCR insulin-stimulated, HCR basal, and HCR insulin-stimulated groups at respective
times directly preceding tissue harvest (t=0 min. for basal groups and t=120 min. for
insulin-stimulated groups). In addition, insulin-stimulated groups of LCR and HCR rats
were analyzed at both t=0 min. and t=120 min. Analysis protocol was carried out using
the Rat Metabolic Magnetic Bead Panel by Milliplex® MAP Kit (Merck, Cat.
#RMHMAG-84K). Antibody-immobilized beads were sonicated for 30 seconds and then
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vortexed for 10 seconds. 150.0 µL of antibody was transferred and diluted in a mixing
bottle with 2.85 mL of bead diluent (LE-BD). Quality controls 1 and 2 (RMH-6084) were
reconstituted by adding 250.0 µL deionized water to each vial. These were vortexed and
allowed to sit for 10 minutes before loading into a 96-well plate. Wash buffer (L-WB)
was prepared by diluting 30.0 mL 10X wash buffer with 270.0 mL deionized water. 1.0
mL deionized water was added to reconstitute serum matrix (LRGT-SM) and this was
allowed to sit 10.0 minutes prior to loading. Standards were prepared by reconstituting
the metabolic standard (RMH-8084) with 250.0 µL deionized water and vortexing for 10
seconds. The vial was left to sit 10.0 minutes before performing serial dilutions to prepare
a standard curve for the assay.
Two hundred microliters of assay buffer (LE-ABGLP) was added to each well of
a 96-well plate and shaken for 10 minutes at room temperature before decanting the
buffer solution and adding 25.0 µL of serum matrix to each well. 25.0 µL assay buffer
was then added to each well in addition to 25.0 µL of standards, controls, or unknown
plasma samples. 25.0 µL of magnetic beads were added to each well before the plate was
sealed, covered in aluminum foil, and incubated on a shaker at 4.0 oC for 18 hours.
All reagents were allowed to come to room temperature before well contents were
decanted. The plate was washed three times by first allowing the plate to rest upon a
magnetic block for 60.0 seconds. Well contents were decanted, then the plate was washed
with 200.0 µL wash buffer and shaken for 30 seconds at room temperature. After that, the
plate was reattached to the magnet and allowed to sit for 60.0 seconds before again
decanting. Immediately following the washing steps, 50.0 µL detection antibodies
(RMH-1084) were added to each well. The plate was covered and shaken at room
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temperature for 30.0 minutes. Then, without decanting, 50.0 µL StreptavidinPhycoerythrin ((L-SAPE12) was added to each well and the plate was again covered and
shaken for 30.0 minutes at room temperature. The 96-well plate was then washed three
times in the same way mentioned previously. Finally, 100.0 µL wash buffer was added to
resuspend the beads before the plate was read using Luminex xPONENT (Merck)
software. Data from Luminex xPONENT were analyzed as mean fluorescence intensity
and were saved in Excel files for analysis.
Total Akt and pAKT levels in each sample of muscle homogenate were also
measured. A 2-plex total/phosphor Akt Magnetic Bead Kit (Cat. #48-618MAG) was used
to analyze Akt content. To begin, reagents were prepared for the immunoassay per
protocol guidelines. The 20x stock magnetic bead solution was sonicated for 15.0
seconds and then vortexed for 30.0 seconds. The beads (42-618MAG) were diluted to 1x
concentration by transferring 150.0 µL stock solution into a mixing bottle with 2.85 mL
assay buffer 2 (43-041). The biotin-labeled antibody was prepared by vortexing a 20x
stock solution (44-618MAG) for 10.0 seconds and diluting 150.0 µL in a mixing bottle
with 2.85 mL assay buffer 2. Streptavidin-Phycoerythrin (45-001H) was vortexed for
10.0 seconds and diluted by combining 120.0 µL in a mixing bottle with 2.88 mL assay
buffer 2. Control cell lysates (47-205 and 47-216) were each reconstituted with 100.0 µL
Millipore® water before being vortexed gently and incubated for 5.0 min at room
temperature. 150.0 µL assay buffer 2 was then added to each cell lysate vial and the vials
were vortexed gently before use in the assay.
All sample homogenate muscle concentrations were calculated using the standard
curve. The samples were first allowed to thaw on ice before being diluted to 1.6 µg/µL
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with working lysis buffer. Muscle samples were stored on ice per protocol
recommendation. These samples were further diluted 1:1 with assay buffer 2 as suggested
in the protocol, giving a final concentration of 20 µg in a 25 µL aliquot (20 µg / 25 µL
after a 1:1 dilution with assay buffer 2).
Fifty microliters of assay buffer 2 was added to each well of a clean 96-well plate.
The plate was covered and shaken at room temperature for 10.0 minutes. Assay buffer
was decanted and 25.0 µL of the vortexed 1x bead suspension was added to each well.
Following bead addition, 25.0 µL assay buffer, controls, and muscle homogenate samples
were added to appropriate wells. The plate was sealed, covered in aluminum foil, and
shaken at 4.0 oC for 20 hours.
Following cold incubation, the plate was washed with assay buffer two times as
described previously. 25.0 µL of 1x detection antibody was added to each well and the
plate was shaken at room temperature for 1 hour. The plate was attached to a magnetic
block for 60.0 seconds and the antibody was decanted before the addition of 25.0 µL
Streptavidin-Phycoerythrin to each well. The plate was again sealed and shaken for 15.0
min at room temperature. Without decanting the Streptavidin-Phycoerythrin, 25.0 µL
amplification buffer (43-024A) was added. The plate was sealed again and shaken for
15.0 min at room temperature. Finally, the plate was attached to a magnetic block for
60.0 seconds before decanting the Streptavidin-Phycoerythrin and amplification buffer.
Beads were resuspended with the addition of 150.0 µL assay buffer 2 in each well. The
plate was shaken for 5.0 minutes at room temperature before reading the plate with
Luminex xPONENT software.
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Data from Luminex xPONENT were saved as mean fluorescence intensity and
stored in an Excel file.

Statistical Analysis
Significance was initially set at α=0.05. Two-tailed student’s t-tests were
performed on sample sizes greater than n=13 to compare body masses, food
consumption, and rate of body mass increase. For in vivo data with small sample sizes,
means were compared using Cohen’s d with 95% confidence intervals. As mentioned
previously, findings that appeared significant were further supported with two-tailed
student’s t-tests or wilcoxen-rank-sum to obtain p-values. Data are represented as mean
+/- SEM.
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RESULTS

Body Weight Gain and Food Consumption
Matching the rats based on body mass was a good way to exclude extraneous
variables in the research design. Weight-matching the rats into separate groups yielded a
negligible difference in mass at week 12 as well as at the time of tissue harvesting
(Appendix A). Body weights were recorded weekly during a 12-week observational
period, with LCR rats observed to have significantly higher body mass each week as
compared to HCR rats, p<0.001 (Figure 13A).
Ad-libitum food consumption was observed to be constant over 12-week
observation for both LCR and HCR groups (Figure 13B). LCR and HCR absolute food
consumption data appear to overlap each week, showing no difference in consumption
(p=0.86). Over the 12-week observational period, LCR and HCR rat groups gained
appreciable mass (Figure 13A); however, HCR rats appeared to consume more food
relative to body mass than LCR rats (Figure 14). Further supporting this observation, the
rate at which mass was gained (Figure 15) was greater in LCR rats as compared to HCR
rats (p<0.05). These data begin to suggest that intrinsic aerobic capacity may be
responsible for the observed differences in basal metabolic rate (also see Appendix B).
Together, these data may indicate a few things: HCR rats may have an increase in cage
activity as compared to LCR rats, HCR rats may have heightened metabolic rate as
compared to LCR rats, or the observed difference in basal metabolic rate between LCR
and HCR rats may result from a combination of these suggestions.
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Figure 13: Body mass and food consumption during 12-week observation. A) Aerobic
capacity influences body mass. LCR rats exhibited higher body masses than HCR rats
during each week throughout the 12-week observation. Standard error bars are displayed
for each week, with no overlap seen between groups. Both LCR and HCR rats appeared
to have a positive rate of change in body mass. B) Food consumption did not differ
between low and high aerobic capacity rat cohorts. Consumption appeared to be constant
throughout 12-week observation with standard error bars shown to be overlapping
(p=0.86), ***p<0.001.
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Figure 14: Food consumption of rat cohorts relative to body weight during 12-week
observation. These data were transformed from figure 13, shown above. HCR rats
appeared to consume more food relative to body weight than LCR rats, consistent
throughout the entirety of observation.
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Figure 15: Side-by-side boxplots compare the rate of body mass change in low and high
aerobic capacity rat models. Rate was calculated as total mass gained over time (g/week).
It appeared there is a higher median rate of change in the LCR group (n=14) as compared
with the HCR group (n=14). In addition, there appeared to be a slight positive skew in the
HCR data as the median line is closer to the 75th percentile than to the 25th percentile.
However, there did not appear to be any outliers in this dataset. The distribution of LCR
appeared normal and without any outliers. The mean of each dataset were significantly
different, *p<0.05.
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Insulin Sensitivity is Reduced in LCR Rats During a Euglycemic-Hyperinsulinemic
Clamp
A euglycemic-hyperinsulinemic clamp was performed as previously described
above. After a 5-hour fast, baseline blood glucose readings did not differ between LCR
and HCR rats at t=-10 min and t=0 min (p=0.47 and p=0.32, respectively). At t=0 min.
hematocrit readings were taken and compared to levels taken at t=120 min. to ensure
similar and minimal blood loss during the clamp procedure. Reliable and effective clamp
data will have minimal blood loss and no difference in blood loss between groups. This
study observed on average a 13% decrease in hematocrit levels for LCR and HCR rats,
with no significant difference in hematocrit decrease between LCR and HCR rats
following the clamp (p=0.45, data not shown). A metabolic clamp proceeds over 120
minutes with literature data suggesting a successful clamped value of blood glucose
around 130 mg/dL, determined by the average value of the final few readings (Ayala et
al. 2006). This supports a clamped value as being the average of values obtained between
t=90 min. and t=120 min. Figure 16 shows the progression of blood glucose readings in
LCR and HCR rats throughout the duration of the metabolic clamp procedure. There was
no difference observed between LCR and HCR rat blood glucose levels between t=90
min. and t=120 min. (p=0.86, Figure 16A). LCR rats were observed to have an average
clamped value of 130.5 mg/dL whereas HCR rats had an average clamped value of 134.2
mg/dL. These data yielded a Cohen’s d value of 0.1324 (-1.31, 1.56) which further
suggest there was no difference in clamped blood glucose levels during LCR and HCR
metabolic clamp procedures, as standard error bars overlap (Figure 16B).
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Figure 16: Blood glucose levels during metabolic clamp. Panel A) shows blood glucose
levels during the metabolic clamp procedure. LCR (n=3) and HCR (n=5) rats had similar
fasting glucose levels at t=-10 min. Blood glucose levels appear to follow a similar
pattern as time progresses, eventually toward a targeted blood glucose reading of about
130 mg/dL. Literature data suggest clamped values of blood glucose occur between t=90
min. and t=120 min. During this time interval, no difference was observed between blood
glucose readings for LCR and HCR rats as standard error bars overlap. Panel B) displays
the mean (+/- standard error) clamped values for both LCR and HCR rats. Standard error
bars overlap, suggesting there is no difference in values. When further comparing effect
sizes, a Cohen’s d value of 0.1324 was obtained with a 95% confidence interval of (-1.31,
1.56).
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Glucose infusion rate was measured during the clamp procedure while rats were
administered a constant infusion of insulin at 4 mU/kg/min. At t=30 min. there appears to
start a difference in glucose infusion rate to maintain the clamped value of blood glucose
concentration of 130 mg/dL (Figure 17A). Similar to the graph for blood glucose levels a
clamped value of glucose infusion rate will be the average of the values recorded
coinciding with the values used to determine the clamped value of blood glucose. In this
study, the final 4 values of glucose infusion rate from t=90 min. through t=120 min. were
used to determine a clamped value of glucose infusion. Figure 17A displays the
progression of glucose infusion measurements throughout the duration of the metabolic
clamp procedure. LCR rats were observed to have a clamped glucose infusion rate of
24.25 μg/g/min and HCR rats were observed to require an increased glucose infusion rate
of 31.35 μg/g/min (p<0.05). A Cohen’s d value of 1.856 (0.047, 3.569) was obtained for
glucose infusion rate data, with no observed overlap in standard error bars (Figure 17B).
Together, these data suggest that low intrinsic aerobic capacity causes insulin resistance.

Low Aerobic Capacity Reduces Soleus Muscle Mass, But Not Total Akt Content
There was no significant difference observed between soleus muscle mass in LCR
and HCR rats (p=0.624). Error bars overlap with a 95% confidence interval of (-15.0,
28.5), further supporting the observation that there was no difference in soleus muscle
mass (Figure 18A). Relative to body mass, HCR rats were observed to have increased
soleus muscle mass when compared to LCR rats (p<0.001). The ratio of soleus muscle
mass to total body mass appeared to be increased 1.5-fold in HCR rats as compared to
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Figure 17: Glucose infusion rates during metabolic clamp. Panel A) displays the effect of
aerobic capacity on glucose infusion rate. LCR (n=3) rats appeared to require lower rates
of glucose infusion to maintain euglycemia during a clamp procedure than HCR (n=5)
rats. Literature data suggest glucose infusion rate to be defined by the values recorded
from t=90 min. through t=120 min. The data support a difference in average glucose
infusion rate during these observations. Standard error bars are displayed for all time
points with no observed overlap during t=100 min, t=110 min, nor t=120 min, which
suggests a significant difference in glucose infusion rates. Panel B) displays the mean
glucose infusion rate (+/- standard error) for LCR and HCR rats during the defined time
points of t=90 min. through t=120 min. Standard error bars are displayed with no overlap,
suggesting a significant difference between the two populations. Upon further
comparison using effect sizes, a Cohen’s d value of 1.856 was obtained with a 95%
confidence interval of (0.047, 3.569), *p<0.05.
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Figure 18: Aerobic capacity does not appear to directly influence soleus muscle mass,
but may influence overall lean body mass. A) LCR rats (n=7) did not appear to have a
significant difference in soleus muscle mass as compared to HCR rats (n=12). A p-value
of 0.624 was obtained with 95% confidence interval of (-15.0, 28.5), which further
suggests that aerobic capacity does not influence soleus muscle mass. B) Relative to
overall body mass, HCR rats (n=12) exhibited a significantly greater proportion of soleus
muscle mass as compared with LCR rats (n=7) which might suggest a role of intrinsic
aerobic capacity in lean body mass, ***p<0.001.
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LCR rats (Figure 18B). These data may suggest that high intrinsic aerobic capacity is
associated with locomotor muscles as compared to low intrinsic aerobic capacity.
As a measure of skeletal muscle insulin signaling, total Akt content was determined in
both LCR and HCR rats (Figure 19). These data suggested no difference in total soleus
muscle Akt content between LCR and HCR rats (p=0.482). A Cohen’s d value of 0.378 (0.568, 1.313) was obtained to further support the observation. Collectively these results
indicate that while aerobic capacity might not influence total Akt in comparable samples,
aerobic capacity is associated with the size of the soleus muscle.

Aerobic Capacity and Skeletal Muscle Akt(Ser473) Phosphorylation Following
Insulin Stimulation
Plasma insulin concentrations were recorded in all groups immediately prior to
tissue harvest. Aerobic capacity had no effect on LCR- and HCR-basal group insulin
concentration (Figure 20A). Upon insulin stimulation, an increase in plasma insulin
concentration was observed in HCR rats as expected (p<0.05). It appeared that LCR rats
also had an increase in plasma insulin concentration upon insulin stimulation. For LCR
rats, a Cohen’s d value of 2.174 (0.130, 2.174) was obtained. Since the 95% confidence
interval does not include 0, these data suggest a significant increase in plasma insulin
levels as a result of insulin stimulation. These data did not yield a p-value of less than
0.05 only because variances were not assumed to be equal, it should be noted that the
error bars do not overlap and that Cohen’s d confidence interval supports a difference.
Taken together, these data support a difference in insulin concentration between basal
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Figure 19: Aerobic capacity does not appear to influence total Akt content within
skeletal muscle tissue. Data are presented as the mean value +/- standard error. There was
no significant difference observed in the total amount of Akt within soleus muscle tissue
of LCR rats (n=7) and HCR rats (n=12). Statistical analysis yielded a Cohen’s d value of
0.378 with a 95% confidence interval of (-0.568, 1.313). Error bars overlap with p=0.482
and a 95% confidence interval of the difference in means being (-186.0, 336.63).
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Figure 20: Plasma insulin concentration at time of tissue harvest and during the
metabolic clamp procedure. A) There appears to be a 4-fold increase in plasma insulin
concentration between HCR basal (n=7) and HCR insulin (n=5) groups. Statistical
analysis of effect sizes gives Cohen’s d value of -2.3268 (-3.821, -0.769). An apparent 5fold increase in plasma insulin concentration between LCR basal (n=4) and LCR insulin
(n=3) yielded Cohen’s d value of 2.174 (0.130, 2.174). There was no observed difference
between basal groups of LCR and HCR as Cohen’s d = 0.224 (-1.015, 1.451). Similarly,
no difference was observed between insulin-stimulated groups of LCR and HCR as
Cohen’s d = -0.373 (-1.804, 1.088). B) Plasma insulin concentration increased during the
metabolic clamp procedure, yielding about a 3-fold increase in HCR rats [Cohen’s d = 1.065 (-2.379, 0.304)] and a 2.5-fold increase in LCR rats [Cohen’s d = -1.268 (-3.021,
0.601)] between t=0 min. and t=120 min. There did not appear to be a difference between
HCR and LCR plasma insulin concentration neither at t=0 min. (-1.707, 1.172) nor t=120
min. (-1.399, 1.464) which suggests similar clearance in plasma insulin, *p<0.05.
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and insulin-stimulated groups while negating any difference in insulin administration
between LCR and HCR rats.
During the euglycemic-hyperinsulinemic clamp, HCR rats were observed to have
an increase in plasma insulin concentration at t=120 min. when compared with t=0 min.
(p<0.05, Figure 20B). Data suggest a 3-fold increase in plasma insulin concentration
upon insulin administration throughout the clamp procedure. LCR rats appear likely to
have observed an increase in plasma insulin at t=120 min. as compared with t=0 min.
with a Cohen’s d value of -1.268 (-3.021, 0.601). The interval suggests a lack of
significance, probably due to variance and small sample size; however, error bars do not
overlap and there still appears to be a 2.5-fold increase in plasma concentration. Further,
there was no difference between LCR and HCR insulin levels at either t=0 min. (-1.707,
1.172) nor at t=120 min. (-1.1399, 1.464). Together, these data support a successful
clamp procedure and suggest similar insulin clearance in both LCR and HCR rats.
Insulin will cause phosphorylation of Akt at Thr308 and Ser473 before facilitating
GLUT4 translocation to the membrane for glucose uptake. Insulin-stimulated HCR rats
were observed to have an increase in pAkt as compared to basal HCR rats (p<0.05,
Figure 21). This supports the expected observation upon insulin-stimulation.
Insulin-stimulated LCR rats were observed to have a similar fold-change in pAkt
levels as HCR counterparts, but the increase was not statistically significant. A Cohen’s d
value for basal and insulin-stimulated LCR rats was calculated to be -1.1045 (-2.698,
0.578). Error bars appear to overlap even though mean values mimic HCR data. No
difference was observed between HCR basal and LCR basal groups (-1.486, 1.159); no
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Figure 21: Basal and insulin-stimulated pAkt in rats of low and high aerobic capacity.
Data are shown as mean values +/- standard error. Upon insulin administration, there
appears to be an increase in phospho-Akt (Ser473) between HCR basal (n=7) and HCR
insulin-stimulated (n=5) groups. Statistical support is indicated with a Cohen’s d value of
-1.306 and a 95% confidence interval of (-2.559, -0.001). In addition, an increase in
phospho-Akt (Ser473) might exist between LCR basal (n=4) and LCR insulin-stimulated
(n=3) groups with an observed Cohen’s d value of -1.1045 and 95% confidence interval
(-2.698, 0.578). There was no statistical difference between LCR basal and HCR basal
groups as effect size analysis yielded a Cohen’s d value of -0.2587 and a 95% confidence
interval of (-1.486, 1.159). Further, there was no statistical difference between LCR
insulin-stimulated and HCR insulin-stimulated groups as effect size analysis yielded a
Cohen’s d value of -0.0508 and a 95% confidence interval of (-1.48, 1.38) *p<0.05.
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difference was observed between insulin-stimulated groups of LCR and HCR rats (-1.48,
1.38). This figure supports insulin as directly influencing Akt phosphorylation within
soleus muscle tissue and begins to suggest that a difference in Akt phosphorylation might
not depend on aerobic capacity in slow, oxidative muscle fibers.
When pAkt data were normalized to total Akt levels, insulin-stimulated HCR rats
had a greater proportion of pAkt as compared to basal HCR rats (p<0.05, Figure 22).
LCR rats observed similar fold-changes in data; however, the increase was not
statistically significant. The figure shows elevated levels of phspho-Akt (Ser473) relative
to total Akt content in insulin-stimulated soleus muscle tissue of HCR rats (n=5) as
compared to basal HCR rats (n=7). A Cohen’s d value of -0.7184 (-2.244, 0.872) might
suggest that a true difference exists in normalized pAkt values observed between basal
LCR and insulin-stimulated LCR rats. Further, there was no difference observed in
normalized pAkt values between basal groups of HCR and LCR rats (-0.722, 1.785).
There did not appear to be any significant difference in levels of phospho-Akt (Ser473) in
insulin-stimulated soleus muscle tissue of LCR rats (n=3) as compared to basal LCR rats
(n=4). No difference was observed between insulin-stimulated groups of HCR and LCR
rats (-1.626, 1.246). Together, these data suggest that low aerobic capacity may hinder
phosphorylation of Akt(Ser473) in insulin signaling pathways.

58

pAkt / Total Akt
0.045

*

0.04
0.035

Ratio

0.03
0.025
0.02
0.015
0.01
0.005
0
HCR Basal

HCR Insulin
LCR Basal
Group

LCR Insulin

Figure 22: Ratio of phospho-Akt (Ser473) to total Akt content within soleus muscle
tissue. Data are presented as the mean value +/- standard error. No overlap of standard
error occurs, and further analysis of effect sizes yielded a Cohen’s d value of -1.0654
with 95% confidence interval (-2.279, 0.194). Statistical analysis using effect sizes
showed a Cohen’s d value of -0.7184 with 95% confidence interval (-2.244, 0.872).
Further, there was no observed difference between HCR basal and LCR basal groups as
effect size analysis gave Cohen’s d value of 0.499 with 95% confidence interval (-0.722,
1.785). No difference was observed between insulin-stimulated muscle tissue in LCR and
HCR rats as effect size analysis yielded Cohen’s d value of -0.1982 with 95% confidence
interval (-1.626, 1.246). *p<0.05
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DISCUSSION

Aerobic capacity is associated with insulin signaling in vitro, but limited evidence
has been demonstrated in vivo (Lessard et al. 2011; Medeiros et al. 2010). Recent data
supports Akt phosphorylation at Ser473 to be a key, proximal insulin signaling event
related to insulin resistance in humans (Friedrichsen et al. 2010). Therefore, an
association may exist between Akt phosphorylation and in vivo insulin sensitivity. The
present study examined the effect of aerobic capacity on insulin sensitivity and skeletal
muscle insulin signaling in conscious, unrestrained rat models of low and high aerobic
capacities. The focus of this research was to ascertain whether proximal insulin signaling
mechanisms, such as Akt phosphorylation at Ser473, are associated with systemic insulin
resistance.
Several factors limit this study. These include the following: small sample size
(n=3-5), mortality rate during surgical procedures, metabolic clamp complications, and
sensitivity of signaling assays. Small sample sizes were largely due to mortality rate
during surgery. It is interesting to note that HCR rats appeared to recover better from both
catheterization and sham surgeries as compared to LCR rats (data not shown). During the
clamp procedure, tubes disconnected the infusion pumps to catheters for a brief period of
time during two IS metabolic clamps, but these were immediately reattached and
measurements resumed. The euglycemic-hyperinsulinemic clamp procedure was
effective in determining insulin sensitivity of rats completing the clamp proecedure (n=35). However, one LCR-IS rat was excluded from the study because of complications
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during this metabolic clamp procedure. These complications included blood loss from the
arterial line and difficulty maintaining constant infusions of insulin and glucose.
Another source of error may have been a result of establishing the phosphoAkt/total Akt signaling assay in the Morris Lab. Trial runs with select samples did not
initially produce expected fold-changes in phospho-Akt(Ser473) for positive controls. A
new Akt signaling assay was used to troubleshoot the initial observations. The new kit
produced a 1- or 2-fold increase in Akt phosphorylation (Ser473) from baseline to insulinstimulated samples. All remaining samples were then analyzed following this verification
step.
The results obtained support an association between low aerobic capacity and a
greater rate of physiological weight gain (Figures 13, 14, And 15). LCR and HCR rats in
this study began acclimation at 20+/-2 weeks of age. Body mass measurements began at
22+/-2 weeks of age, with there already being a significant difference in mass between
LCR and HCR rats. It is likely that HCR rats were more physically active within housing
cages than LCR rats, thus contributing to differences observed in mass measurements. An
increase in physical activity has been observed in HCR rats as compared to LCR rats
following both normal chow and high-fat diets (Novak et al. 2010). Within skeletal
muscle of LCR and HCR rats, an increase in physical activity was attributed to elevated
levels of PEPCK-C in HCR rats as compared with LCR rats. This enzyme functions in
gluconeogenesis and its overexpression is consistently linked with extended endurance
and longevity (Novak et al. 2010). Thus, it is likely that this contributed to the lower
observed body mass measurements in HCR rats.

61

Ad libitum food consumption was not different between groups (p=0.86), which
suggests absolute caloric intake had no contribution to differences observed in body
mass. Further, HCR rats consumed greater amounts of food relative to body mass each
week as compared with LCR rats. HCR rats consistently weighed less with increased
food consumption per gram of body weight throughout the duration of the study (Figure
14). These data may suggest a greater basal metabolic rate in HCR rats as compared to
LCR rats. Furthermore, the rate of physiological body mass increase was significantly
less in HCR rats than LCR rats (Figure 15). Together, these data support an inherent
difference in physiological weight gained between LCR and HCR rats. Therefore,
elevated energy expenditure due to physical activity and higher basal metabolic rates in
HCR rats could be linked to improved energy homeostasis and decreased body weight as
compared to LCR rats.
These data support previous observations suggesting the association between
physical inactivity and obesity (Tremblay and Willms 2003). Exercise training has been
associated with increases in working aerobic capacity over a defined time interval and
metabolic enzymatic adaptations (Henriksson and Reitmann 1977). Together, these data
begin to suggest physical inactivity might be associated with lower levels of working
aerobic capacity, which can lead to increased weight gain and increased risk of obesity.
In addition, HCR rats had increased insulin sensitivity in vivo through use of a
euglycemic-hyperinsulinemic clamp (Figure 17). This clamp procedure is a ―goldstandard‖ when determining insulin sensitivity (Ayala et al. 2011). LCR rats were
observed to be less insulin-sensitive as compared to HCR rats. The higher observed body
weights in LCR rats as compared with HCR rats may contribute to these observations. As
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mentioned before, the final four time values, t=90-120 min., were used when determining
the mean value of glucose infusion rate (GIR). At t=30 min. GIR (mg/kg/min) began to
diverge between LCR and HCR rats (Figure 17A). The lower GIR (mg/kg/min) observed
in LCR rats is indicative of systemic insulin resistance. Together, these data show aerobic
capacity influences GIR (mg/kg/min) in response to a constant infusion of insulin.
A reduction in GIR suggests LCR rats are more insulin resistant than HCR rats.
The reduction in glucose uptake begins to mimic a TIIDM phenotype, which may support
insulin resistance as a link between physical inactivity and diabetes (Campbell and Reece
2005). Previous studies consistently link physical activity with improved insulin
sensitivity (Lessard et al. 2011; Medeiros et al. 2010; Hamilton et al. 2014). To determine
which part of the insulin signaling pathway was responsible for the reduction in glucose
uptake, soleus muscle tissues were analyzed for total and phosphorylated Akt content,
since Akt phosphorylation is imperative for insulin-stimulated skeletal muscle glucose
uptake (Gonzales and McGraw 2009; Stanford and Goodyear 2014; Figure 23).
Magpix protein assays helped determine the impact of aerobic capacity on
skeletal muscle Akt phosphorylation in vivo (Figures 20, 21, and 22). Our hypothesis was
that LCR rats would have impaired Akt phosphorylation that accompanies the observed
decrease in GIR. HCR rats were observed to have an increase in Akt phosphorylation
upon insulin-stimulation while LCR rats did not demonstrate the same significant
increase in Akt phosphorylation when stimulated with insulin. Aerobic capacity does not
appear to significantly influence the total amount of Akt present within the cell (Figure
20). However, intrinsic aerobic capacity appears to influence the consistency of phosphoAkt(Ser473) and the ratio of phospho-Akt(Ser473) / total Akt in HCR rats. Significant
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increases in absolute and normalized Akt phosphorylation were not observed in LCR rats
(Figures 21 and 22, respectively). Therefore, the observed increase in Akt
phosphorylation in HCR rats is not simply due to an increased amount of Akt. Instead,
these data begin to suggest a reduction in the consistency of Akt phosphorylation in LCRIS rats.
Akt phosphorylation is known to increase upon insulin administration (Bruss et al.
2005). Given this observation, these data suggest that LCR rats may have impairments in
Akt phosphorylation relative to HCR rats. Taken together, these data might be interpreted
to suggest the difference in systemic insulin sensitivity observed between LCR and HCR
rats is mediated through a difference in Akt signaling. Figures 21 and 22 show a
significant increase in phospho-Akt(Ser473) in HCR-IS rats, but not in LCR-IS rats.
However, neither basal nor insulin-stimulated levels of phospho-Akt(Ser473) were
significantly different between LCR-IS and HCR-IS rats (Figures 21 and 22). These
observations do imply a convincing argument for any impairment in insulin-stimulated
Akt phosphorylation. Mean values of total Akt and pAkt did not differ between LCR-IS
and HCR-IS rats, which may indicate intact insulin signaling at the level of Akt
phosphorylation.
The lower value of GIR observed in LCR rats could be attributed to other
mechanisms involved in glucose homeostasis. These may include elevated liver glucose
production or impaired delivery of substrate to insulin-stimulated skeletal muscle.
Together, these data do not provide a convincing argument to suggest low aerobic
capacity is associated with impairments in Akt phosphorylation. Thus, the reduction in
GIR observed in LCR rats might be attributed to a reduction in protein activation
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downstream Akt. A good direction for future studies may be to focus on expression and
activation of TBC1D1, AS160, and GLUT4 (Figure 23).
Small sample sizes likely contributed to high variability in Akt signaling.
Standard error bars overlapped in data presentation of total Akt (Figures 21 and 22), and
increasing sample sizes would reduce standard error. The 95% confidence interval around
Cohen’s d was (-0.568, 1.313), which includes 0 and is interpreted as not being
significant. However, the upper end of this range may indicate a significant difference
exists. Similarly, reducing the observed error in phospho-Akt(Ser473) through an increase
in sample size might strengthen the data (Figures 21 and 22).
Future studies include replicating results and increasing sample sizes. Impaired
insulin-stimulated phosphorylation of Akt could lead to impairments in insulin-stimulated
GLUT4 translocation to the membrane for glucose uptake. Other insulin-stimulated
targets of interest include phosphorylation of AS160 or TBC1D1. These distal
phosphorylation steps have been implicated in both insulin-stimulated and contractioninduced glucose uptake in muscle (Cartree et al. 2007, Taylor et al. 2008). If these data
were replicated and absolute values of Akt phosphorylation did not differ between LCR
and HCR rats, then the impairment in insulin-stimulated glucose uptake must occur distal
to Akt phosphorylation. Skeletal muscle glucose uptake is influenced by insulinstimulation as well as compensatory pathways influenced through exercise (Figure 23).
Glucose uptake and exercise-mediated GLUT4 translocation is not impaired during acute
bouts of exercise in mice lacking skeletal muscle insulin receptors (Stanford and
Goodyear 2015). These findings may provide future avenues for understanding the

65

Figure 23: Exercise and insulin regulation of glucose transport (Stanford and Goodyear
2015). This figure highlights insulin signaling for glucose uptake and proposes several
compensatory mechanisms for GLUT4 translocation upon an exercise-induced increase
in skeletal muscle contraction.
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mechanisms responsible for the observed LCR reduction in GIR as compared to HCR
rats.
These results require further study to clarify the role of aerobic capacity in
skeletal muscle insulin signaling during glucose uptake. Akt phosphorylation will be
analyzed in vastus lateralis (type II fiber) and plantaris (type I and type II fibers) muscle
tissues. If a difference in signaling activity is observed, a proteomic assay will be
performed to assess phosphorylation activity of several metabolic proteins within the cell.
Consistent with previous studies, our data support LCR rats have higher rates of
physiological weight gain compared to HCR rats. LCR rats also had lower GIR during a
euglycemic-hyperinsulinemic clamp as compared to HCR rats. This clamp procedure has
been performed previously in mice (Ayala et al. 2011) and has now been established in
LCR and HCR rats. This rat model has become a powerful tool in exploring potential
epigenetic mechanisms of metabolic abnormalities. Insulin signaling was measured using
Akt as a marker for pathway activity. Akt was selected because it is known to become
phosphorylated upon insulin-stimulation and provides just one of many indications of
insulin responsiveness (Bruss et al. 2005). Total Akt and phospho-Akt (Ser473) were
measured using a multiplex ELISA that allowed for detection of both antibodies within a
single sample. Therefore, the assay reduced error from multiple samples and gave a novel
approach to protein detection within muscle samples. LCR-IS rats showed a reduction in
fold-change expected from insulin-stimulation in both absolute and normalized phosphoAkt(Ser-473) as compared to HCR-IS rats; however, the mean values of total Akt and
phospho-Akt(Ser473) were not different between LCR-IS and HCR-IS rats. This may
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imply distal impairments in glucose uptake, including activation of AS160, TBC1D1, or
total GLUT4 expresison.
To recapitulate, the mechanism(s) linking physical inactivity, diabetes, and
obesity are still unclear; however, insulin resistance is observed in each phenomena and
might be what links these three together. An unbiased, heterogeneous rat model was used
to elucidate the impact of functional aerobic capacity on physiological weight gain,
systemic insulin sensitivity, and insulin-stimulated glucose uptake. Rats of low and high
aerobic capacities provided groups that mimic low and high levels of physical fitness.
Data suggested low aerobic capacity, and therefore lower levels of physical fitness, were
associated with increased physiological weight gain and reductions in insulin sensitivity
as compared to high aerobic capacity, or those with higher levels of physical fitness.
Together, these findings imply an association between physical inactivity, obesity, and
diabetes through reductions in insulin sensitivity. However, insulin signaling data are yet
inconclusive in determining where there is impairment in insulin-stimulated skeletal
muscle glucose uptake (Figures 20, 21, and 22). Future studies may confirm insulin
resistance at the level of Akt in other skeletal muscle fiber types (vastus lateralis type II,
plantaris type I and II) or suggest distal impairments in insulin-stimulated glucose uptake.
In short, insulin resistance appears to be a linking mechanism between diabetes,
physical inactivity, and obesity. We used a nonbiased rat model to assess the impact of
aerobic capacity on insulin-stimulated glucose uptake and Akt activity. The results begin
to suggest a difference in Akt activity between LCR and HCR rats; however, the data are
not yet convincing to make a definite conclusion of insulin signaling impairment at that

68

level. Thus, future studies will either confirm impairment at Akt or suggest distal
impairment in insulin-stimulated glucose uptake.
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APPENDICES

Appendix A

Group assignments of LCR and HCR Rats
Surgery
Age
Group
Mass(g)*
Clamp Mass(g)
ΔMass
Mass(g)
(days)
377.7
377
370.6
6.4
404.3
410.2
370
40.2
486.8
518.5
502.6
15.9
308
HCR
399.2
420
408
12
286
Catheterization
472.7
507
330
472.6
499.9
474.5
25.4
298
374.6
395.5
326
403.2
400.6
392.9
7.7
247
400.9
420.5
389.6
30.9
277
471.6
482.2
480.8
1.4
305
HCR
383.7
392.3
383.9
8.4
277
Sham/Basal
481.5
510
479.4
30.6
339
463.1
479.1
474
5.1
322
384
411.2
408.5
2.7
354
532.8
540
528
12
280
509.3
526.6
408.2
118.4
296
605.7
637.6
602.5
35.1
303
LCR
507.6
523.4
507.5
15.9
302
Catheterization
597.6
625.6
321
485.8
509.4
463.5
45.9
338
495.2
525.9
312
531
531.1
303
531.5
532.5
448.2
84.3
267
559.7
596.8
300
LCR Sham/Basal
540.8
565
563.2
1.8
288
472.3
488.1
338
576.1
608
515.5
92.5
344
525
553.1
545.1
8
335
This table displays group assignments for surgical groups. Rats were weight-matched to
reduce variables. The * refers to mass measurement taken after 12-week observation,
which determined group placement. Actual mass refers to measurement taken on surgery
day while clamp mass refers to mass taken the morning of the euglycemichyperinsulinemic clamp. Clamp mass was the final mass taken before tissue harvesting.
Change in mass was recorded to support adequate recovery from surgery and ages are
displayed to support a negligible effect of age on surgical procedures and data collection.
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Appendix B
Fecal samples were collected by Dr. Tyler Morris at the Jordan Valley Innovation
Center. Total DNA was extracted using Qiagen QiAmp DNA Stool Mini Kit and was
quantified using Nanodrop 2000 before subsequent dilution to 10 ng/µL. The protocol
was modified slightly to yield a higher ratio of bacterial DNA to host DNA. About 50 ng
DNA was loaded into a PCR reaction that targeted bacterial 16s rRNA variable regions
V2 and V3 for species-specific identification. A 40 bp GC clamp was incorporated for
purposes of separation in subsequent gel staining. After product verification, the samples
were loaded into denaturing gradient gel electrophoresis (DGGE). The gel was then
stained with Ethidium Bromide and imaged using UV transillumination.
From the gel image below, a similarity matrix was constructed using Phoretix
software. Based on the similiarities, the UPGMA dendrogram below was constructed to
show relationships between organismal microflora in LCR and HCR rats. These data
suggest that aerobic capacity does not influence gut microflora. A similarity matrix was
constructed with no less than 79% similarity between LCR and HCR samples. These data
may further support the role of aerobic capacity within the cell, affecting mitochondrial
dynamics or insulin signaling pathways. The observed difference in metabolism may
therefore be attributed to aerobic capacity and cannot be associated with microflora
composition.
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Gut microflora composition of LCR and HCR rats. Panel A) DGGE fingerprint generated
from HCR and LCR samples. Lanes are as follows: (1) HCR - 19.6; (2) HCR - 19.14; (3)
HCR – 19.7; (4) HCR – 19.13; (5) LCR – 19.16; (6) LCR – 19.27; (7) LCR – 19.18; (8)
LCR – 19.21. Panel B) UPGMA dendrogram from fecal samples. This representation
classifies and groups sample lanes on the basis of band presence/absence similarities.
Panel C) Similarity matrix generated using Dice similarity index. The boxes shaded in
green denote the comparisons within HCR samples, the Red boxes show comparisons
within LCR samples, and the Blue boxes compare HCR samples to LCR samples.
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